| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |